Trial Profile
A phase II trial of brincidofovir in kidney transplant patients at high risk of BK virus associated diseases
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Brincidofovir (Primary)
- Indications Polyomavirus infections
- Focus Therapeutic Use
- 02 Mar 2016 Status changed from not stated to planning.
- 02 Mar 2016 New trial record